1. Home
  2. XBIO vs ARBB Comparison

XBIO vs ARBB Comparison

Compare XBIO & ARBB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Xenetic Biosciences Inc.

XBIO

Xenetic Biosciences Inc.

HOLD

Current Price

$3.11

Market Cap

7.2M

Sector

Health Care

ML Signal

HOLD

Logo ARB IOT Group Limited

ARBB

ARB IOT Group Limited

HOLD

Current Price

$5.01

Market Cap

6.9M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
XBIO
ARBB
Founded
N/A
1997
Country
United States
Singapore
Employees
2
N/A
Industry
Biotechnology: Pharmaceutical Preparations
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
7.2M
6.9M
IPO Year
N/A
2022

Fundamental Metrics

Financial Performance
Metric
XBIO
ARBB
Price
$3.11
$5.01
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$20.00
AVG Volume (30 Days)
10.6K
28.8K
Earning Date
05-13-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$2.81
N/A
Revenue Next Year
N/A
$24.79
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.90
$3.71
52 Week High
$13.93
$13.89

Technical Indicators

Market Signals
Indicator
XBIO
ARBB
Relative Strength Index (RSI) 55.58 55.06
Support Level $2.94 $3.91
Resistance Level $3.42 $5.04
Average True Range (ATR) 0.15 0.26
MACD 0.01 0.03
Stochastic Oscillator 88.89 70.41

Price Performance

Historical Comparison
XBIO
ARBB

About XBIO Xenetic Biosciences Inc.

Xenetic Biosciences Inc is a biopharmaceutical company focused on advancing immuno-oncology technologies addressing difficult-to-treat cancers. The company's DNase technology is designed to improve outcomes of existing treatments, including immunotherapies, by targeting neutrophil extracellular traps (NETs), which are involved in the progression of many human cancers. Xenetic is also focused on advancing its systemic DNase program into the clinic as an adjunctive therapy for pancreatic carcinoma and other locally metastatic solid tumors. Its product pipeline consists of two key programs, XBIO-015 and XBIO-020, which are being developed to address pancreatic carcinoma and solid tumours.

About ARBB ARB IOT Group Limited

ARB IOT Group Ltd is a provider of complete solutions to the clients for the integration of Internet of Things (IoT) systems and devices from designing to project deployment. The company offers a wide range of IoT systems as well as provides customers with a substantial range of services such as system integration and system support services. It delivers solutions like designing, installation, testing and commissioning of various IoT systems and devices as well as integration of automated systems, including installation of wire and wireless and mechatronic works. The company operates in two reportable segments: (i) the provision of hardware and software of IoT solutions and (ii) Investment holding and others. The majority of revenue is generated from the IoT solutions segment.

Share on Social Networks: